{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:15:57Z","timestamp":1791875757620,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07775-z","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:17:32Z","timestamp":1759169852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["External validity of cardiovascular risk assessment tools in individuals with MASLD (NAFLD): a cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Nima","family":"Motamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoodreza","family":"Khoonsari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hadi","family":"Karbalaie Niya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahshid","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Ajdarkosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansooreh","family":"Maadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhayaneethie","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Safarnezhad Tameshkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahareh","family":"Amirkalali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maziar","family":"Moradi-Lakeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"7775_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986 (2023).","journal-title":"Hepatology"},{"key":"7775_CR2","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba, R. & Sanyal, A. J. The global NAFLD epidemic. Nat. Reviews Gastroenterol. Hepatol. 10, 686 (2013).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"key":"7775_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/hep.28524","volume":"64","author":"M Rinella","year":"2016","unstructured":"Rinella, M. & Charlton, M. The globalization of nonalcoholic fatty liver disease: prevalence and impact on world health. Hepatology 64, 19\u201322 (2016).","journal-title":"Hepatology"},{"key":"7775_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrgastro.2013.34","volume":"10","author":"GC Farrell","year":"2013","unstructured":"Farrell, G. C., Wong, V. W. S. & Chitturi, S. NAFLD in Asia\u2014as common and important as in the West. Nat. Reviews Gastroenterol. Hepatol. 10, 307 (2013).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"key":"7775_CR5","first-page":"149","volume":"7","author":"I Moghaddasifar","year":"2016","unstructured":"Moghaddasifar, I. et al. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int. J. Organ. Transplantation Med. 7, 149 (2016).","journal-title":"Int. J. Organ. Transplantation Med."},{"key":"7775_CR6","unstructured":"Tabaeian, S. P. et al. Prevalence of non-alcoholic fatty liver disease in Iran: A systematic review and meta-analysis. J. Clin. Exp. Hepatol. (2023)."},{"key":"7775_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/gutjnl-2011-300342","volume":"61","author":"VWS Wong","year":"2012","unstructured":"Wong, V. W. S. et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut 61, 409\u2013415 (2012).","journal-title":"Gut"},{"key":"7775_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.1478-3231.2008.01718.x","volume":"29","author":"NC Leite","year":"2009","unstructured":"Leite, N. C., Salles, G. F., Araujo, A. L., Villela-Nogueira, C. A. & Cardoso, C. R. Prevalence and associated factors of non\u2010alcoholic fatty liver disease in patients with type\u20102 diabetes mellitus. Liver Int. 29, 113\u2013119 (2009).","journal-title":"Liver Int."},{"key":"7775_CR9","first-page":"205","volume":"57","author":"M Prashanth","year":"2009","unstructured":"Prashanth, M. et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J. Assoc. Physicians India. 57, 205\u2013210 (2009).","journal-title":"J. Assoc. Physicians India"},{"key":"7775_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64, 73\u201384 (2016).","journal-title":"Hepatology"},{"key":"7775_CR11","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.jacc.2016.01.070","volume":"67","author":"I Zeb","year":"2016","unstructured":"Zeb, I. et al. Nonalcoholic fatty liver disease and incident cardiac events: the multi-ethnic study of atherosclerosis. J. Am. Coll. Cardiol. 67, 1965\u20131966 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"7775_CR12","first-page":"204","volume":"22","author":"N Sarrafzadegan","year":"2019","unstructured":"Sarrafzadegan, N. & Mohammmadifard, N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch. Iran. Med. 22, 204\u2013210 (2019).","journal-title":"Arch. Iran. Med."},{"key":"7775_CR13","unstructured":"Goff, D. C. et al. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 63, 2935\u20132959 (2014)."},{"key":"7775_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019agostino","year":"2008","unstructured":"D\u2019agostino, R. B. et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation 117, 743\u2013753 (2008).","journal-title":"Circulation"},{"key":"7775_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"R Conroy","year":"2003","unstructured":"Conroy, R. et al. Estimation of ten-year risk of fatal cardiovascular disease in europe: the SCORE project. Eur. Heart J. 24, 987\u20131003 (2003).","journal-title":"Eur. Heart J."},{"key":"7775_CR16","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 risk prediction","year":"2021","unstructured":"SCORE2 risk prediction. Algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 42, 2439\u20132454 (2021).","journal-title":"Eur. Heart J."},{"key":"7775_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1478-3231.2011.02753.x","volume":"32","author":"S Treeprasertsuk","year":"2012","unstructured":"Treeprasertsuk, S. et al. The F Ramingham risk score and heart disease in nonalcoholic fatty liver disease. Liver Int. 32, 945\u2013950 (2012).","journal-title":"Liver Int."},{"key":"7775_CR18","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"G Collaborators","year":"2020","unstructured":"Collaborators, G. & \u00c4rnl\u00f6v, J. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet 396, 1223\u20131249 (2020).","journal-title":"Lancet"},{"key":"7775_CR19","doi-asserted-by":"publisher","first-page":"1329380","DOI":"10.3389\/fendo.2024.1329380","volume":"15","author":"N Motamed","year":"2024","unstructured":"Motamed, N. et al. A population-based prospective study on obesity-related non-communicable diseases in Northern iran: rationale, study design, and baseline analysis. Front. Endocrinol. 15, 1329380 (2024).","journal-title":"Front. Endocrinol."},{"key":"7775_CR20","doi-asserted-by":"crossref","unstructured":"Hosmer, D. W., Lemeshow, S. & Sturdivant, R. X. Applied Logistic Regression, vol. 398 (Wiley, 2013).","DOI":"10.1002\/9781118548387"},{"key":"7775_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41512-019-0064-7","volume":"3","author":"AJ Vickers","year":"2019","unstructured":"Vickers, A. J., van Calster, B. & Steyerberg, E. W. A simple, step-by-step guide to interpreting decision curve analysis. Diagn. Prognostic Res. 3, 1\u20138 (2019).","journal-title":"Diagn. Prognostic Res."},{"key":"7775_CR22","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.dld.2014.04.002","volume":"46","author":"CE de Keyser","year":"2014","unstructured":"de Keyser, C. E. et al. Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals. Dig. Liver Disease. 46, 720\u2013725 (2014).","journal-title":"Dig. Liver Disease"},{"key":"7775_CR23","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/MAJ.0b013e318213e526","volume":"342","author":"L Maroni","year":"2011","unstructured":"Maroni, L. et al. Lipid targets during Statin treatment in dyslipidemic patients affected by nonalcoholic fatty liver disease. Am. J. Med. Sci. 342, 383\u2013387 (2011).","journal-title":"Am. J. Med. Sci."},{"key":"7775_CR24","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.arcmed.2013.12.003","volume":"45","author":"ET Oni","year":"2014","unstructured":"Oni, E. T. et al. Statin use is not associated with presence of and severity of nonalcoholic fatty liver disease. Arch. Med. Res. 45, 52\u201357 (2014).","journal-title":"Arch. Med. Res."},{"key":"7775_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1592\/phco.28.4.522","volume":"28","author":"MD Onofrei","year":"2008","unstructured":"Onofrei, M. D., Butler, K. L., Fuke, D. C. & Miller, H. B. Safety of Statin therapy in patients with preexisting liver disease. Pharmacother. J. Hum. Pharmacol. Drug Therapy. 28, 522\u2013529 (2008).","journal-title":"Pharmacotherapy: J. Hum. Pharmacol. Drug Therapy"},{"key":"7775_CR26","unstructured":"Gillett, R. C. & Norrell, A. Considerations for safe use of statins: liver enzyme abnormalities and muscle toxicity. Am. Fam. Phys. 83 (2011)."},{"key":"7775_CR27","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jacl.2014.02.011","volume":"8","author":"H Bays","year":"2014","unstructured":"Bays, H., Cohen, D. E., Chalasani, N. & Harrison, S. A. An assessment by the Statin liver safety task force: 2014 update. J. Clin. Lipidol. 8, S47\u2013S57 (2014).","journal-title":"J. Clin. Lipidol."},{"key":"7775_CR28","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1001\/jama.2014.2632","volume":"311","author":"M Kavousi","year":"2014","unstructured":"Kavousi, M. et al. Comparison of application of the ACC\/AHA guidelines, adult treatment panel III guidelines, and European society of cardiology guidelines for cardiovascular disease prevention in a European cohort. Jama 311, 1416\u20131423 (2014).","journal-title":"Jama"},{"key":"7775_CR29","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1111\/jgh.12665","volume":"29","author":"M Otgonsuren","year":"2014","unstructured":"Otgonsuren, M. et al. A single non-invasive model to diagnose non\u2010alcoholic fatty liver disease (NAFLD) and non\u2010alcoholic steatohepatitis (NASH). J. Gastroenterol. Hepatol. 29, 2006\u20132013 (2014).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"7775_CR30","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu, V. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128, 1898\u20131906 (2005).","journal-title":"Gastroenterology"},{"key":"7775_CR31","unstructured":"Wieckowska, A. & Feldstein, A. E. Seminars in Liver Disease. 386\u2013395 (Thieme Medical Publishers)."},{"key":"7775_CR32","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/hep.22742","volume":"49","author":"DC Rockey","year":"2009","unstructured":"Rockey, D. C., Caldwell, S. H., Goodman, Z. D., Nelson, R. C. & Smith, A. D. Liver biopsy. Hepatology 49, 1017\u20131044 (2009).","journal-title":"Hepatology"},{"key":"7775_CR33","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh, S. et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 123, 745\u2013750 (2002).","journal-title":"Gastroenterology"},{"key":"7775_CR34","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797\u20131835 (2023).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07775-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07775-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07775-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:17:35Z","timestamp":1759169855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07775-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7775"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07775-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"25 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33462"}}